A new study published in JAMA Network Open has identified that frequent use of continuous glucose monitoring devices is strongly associated with better long-term glycemic control among people with type 2 diabetes. These findings stress that it is not periodic monitoring but the consistent use of CGM that will play a vital role in sustaining glycemic improvement and optimizing diabetes management. The study was conducted by Irl B. and colleagues.
Poor glycemic control is the fundamental driver of diabetes-related complications, and while CGM adoption has increased in the management of type 2 diabetes, evidence linking frequency of use to measurable clinical outcomes has remained scant. This large-scale study fills that gap by analyzing real-world data to establish a clear relationship be

 Medical Dialogues

 AlterNet
 RadarOnline